TER · Teradyne, Inc. — research history

The dossier flags anti-signals (dilution, pump signals) that trigger hard gates, and the stock trades at a steep valuation premium (43x Fwd P/E, 55x EV/EBITDA) after a 183% YTD run, leaving no margin of safety or high-conviction income structure. Insider activity is limited to scheduled 10b5-1 sales, and the Nasdaq 100 inclusion catalyst is already fully priced in with no asymmetric upside.

The dossier flags anti-signals (dilution, pump signals) that trigger hard gates, and the stock trades at a steep valuation premium (43x Fwd P/E, 55x EV/EBITDA) after a 183% YTD run, leaving no margin of safety or high-conviction income structure. Insider activity is limited to scheduled 10b5-1 sales, and the Nasdaq 100 inclusion catalyst is already fully priced in with no asymmetric upside.

Teradyne has had extraordinary price appreciation (+183% YTD) driven by AI/semiconductor demand and strong Q1 results (EPS $2.56 vs $2.12 est). The Form 4 cluster that triggered this investigation consists entirely of pre-scheduled 10b5-1 sales from the CEO ($1.69M on June 15 at $423.03) and a director — not opportunistic buys. No insider purchases were found in any recent window. The stock is near its 52-week high at $409, with forward P/E at 43x and EV/EBITDA at 55x — both expensive versus semis sector norms (~20-25x forward P/E). The most concrete bullish catalyst is Nasdaq 100 inclusion effective June 22, which will generate passive buying pressure from index funds. Quality metrics are excellent (ROIC ~28.75%, gross margins ~59%), but valuation provides no margin of safety for a long-only thesis at current levels.

Stock is up 166% YTD and trades at a massive valuation premium (38.9x Fwd P/E, 49.6x EV/EBITDA) with zero insider buying and unreliable options data; the AI growth thesis is fully priced in, leaving no asymmetric upside or reliable income structure to recommend.

Teradyne is a semiconductor test and robotics company that has had exceptional Q1 2026 results (revenue +87% YoY to $1.28B; EPS $2.56 vs. $2.12 estimate — a +20.9% beat), driven by AI-related demand across its segments (~70% of sales now tied to AI). However, the stock is up ~166% YTD and trades at 38.9x forward P/E and 49.6x EV/EBITDA — stretched even for a high-growth semicap name. The investigation trigger (Form 4 cluster) was examined closely: both June 2026 filings were RSU tax-withholding dispositions (code F), not open-market purchases. There is no material insider buying signal. AI tailwinds are real but already priced in at this multiple, and the next earnings beat may be difficult to achieve at this scale of expectations.

Score falls well below the 45 threshold due to a complete absence of mispricing (41x forward P/E and 52x EV/EBITDA vs sector medians) and zero smart-money conviction. The AI tailwind is already fully priced in at all-time highs, and the reported anti-signals (liquidity/pump flags) are likely false positives for a $61.5B cap name but further reinforce the need to pass.

Teradyne has had a spectacular run (YTD +81%) driven by AI-linked semiconductor test demand representing ~70% of revenue. Q1 2026 earnings smashed estimates (+21% EPS beat). However, at forward P/E of 41x and EV/EBITDA of 52.8x, the stock is at/near all-time highs with no margin of safety for a long thesis. The two recent Form 4 filings that triggered this investigation are both routine — Shannon Poulin (President, Semiconductor Test) exercised options and sold pursuant to pre-set Rule 10b5-1 plans; Marilyn Matz (Director) made a small discretionary sale at market. Neither represents insider conviction buying. Options flow shows call-bias but no whale blocks. The elevated IV (~77%) creates an attractive income thesis on the stock near its ceiling.

{"symbol":"TER","company":"Teradyne, Inc.","investigation_summary":"Teradyne is a semiconductor test and robotics company that has surged ~240% over the past year on AI-driven chip testing demand (AI now ~70% of revenue mix). The Form 4 cluster triggering this investigation consisted entirely of pre-scheduled 10b5-1 selling by insiders executing option exercises — zero open-market purchases. Q1 EP

Stock trades at a demanding 34x forward P/E with zero margin of safety after a 363% one-year run, lacks insider buying, and carries active anti-signal flags (dilution, pump signals) that outweigh any income structure potential.

Teradyne has had an extraordinary run (YTD +172%, 1yr +363%) driven by AI-linked semiconductor test demand now constituting ~70% of revenue. Q1 2026 EPS crushed estimates ($2.56 actual vs $2.12 est) and Q4 FY25 beat by 30%. However, the investigation revealed that all 10 Form 4 filings in the past 14 days are either RSU grants (A code at $0 — not purchases), or sales under pre-established Rule 10b5-1 plans from multiple insiders including CEO Smith. There are ZERO open-market insider PURCHASES in the dataset. The stock is near its 52w high ($321 vs $422 peak, ~24% below) and trades at a demanding forward P/E of ~34x versus typical semiconductor equipment peer medians in the low-20s; EV/EBITDA of ~43x is similarly stretched. Technically, RSI is neutral zone (41.9), stock below both its 20DMA and 50DMA, and MACD gave a bearish cross 14 bars ago. The bull case (AI tailwinds, beat-and-raise cadence) is already priced in at current levels with no margin of safety for an asymmetric long.

{"symbol":"TER","company":"Teradyne, Inc.","investigation_summary":"Teradyne reported Q1 FY2026 earnings that were massively ahead of estimates ($2.56 actual vs $2.12 est) with revenue of $1.28B driven by ~70% AI-related demand, yet the stock has pulled back ~14% from its 52-week high of $422 despite being up ~362% over the past year. The company trades at a steep forward P/E of 38x and EV/EBITDA